Trials / Conditions / Clinical Stage IV Esophageal Adenocarcinoma AJCC v8

Clinical Stage IV Esophageal Adenocarcinoma AJCC v8

11 registered clinical trials studyying Clinical Stage IV Esophageal Adenocarcinoma AJCC v8 — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, NCT05911243	University of Washington	N/A
Recruiting	Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial NCT06203600	National Cancer Institute (NCI)	Phase 2 / Phase 3
Recruiting	Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Loca NCT05651594	Roswell Park Cancer Institute	Phase 2
Recruiting	mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastati NCT05677490	Alliance for Clinical Trials in Oncology	Phase 3
Active Not Recruiting	Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events NCT05038254	M.D. Anderson Cancer Center	N/A
Active Not Recruiting	Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Eso NCT04460937	National Cancer Institute (NCI)	Phase 1
Active Not Recruiting	National Cancer Institute "Cancer Moonshot Biobank" NCT04314401	National Cancer Institute (NCI)	—
Active Not Recruiting	Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Ga NCT04248452	ECOG-ACRIN Cancer Research Group	Phase 3
Completed	Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study NCT04449679	Thomas Jefferson University	N/A
Completed	Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes NCT04501913	City of Hope Medical Center	—
Completed	Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma NCT03395847	M.D. Anderson Cancer Center	EARLY_Phase 1